Advanced K-Beauty Access: Global Availability Guide (May 2026)
Advanced K-Beauty Access: Global Availability Guide (May 2026)
At ISANG DERMATOLOGY, we understand that our international patients value both safety and innovation. One of the most common questions we receive is: "Can I continue this treatment when I return home?"
Korea is globally recognized as a pioneer in aesthetic medicine. Many of the premium treatments we offer are available in Seoul years before they receive regulatory clearance in other countries. This provides a unique window for our patients to experience next-generation skin technology while visiting Korea.
As of May 2026, we have updated our global licensing guide. Treatments marked with an "X" are currently undergoing clinical trials or the approval process in that region—meaning your visit to Seoul may be the perfect opportunity to access these advanced procedures.
| ISANG's Primary Selection | USA | China | Japan | Taiwan |
|---|---|---|---|---|
| Thermage FLX / Ultherapy | O | O | O | O |
| XERF (Advanced RF) | O | X | O | O |
| InMode (RF) | O | O | O | O |
| HIFU: Shurink / TenThera | X | X | O | O |
| ISANG's Primary Selection | USA | China | Japan | Taiwan |
|---|---|---|---|---|
| Rejuran (Polynucleotide) | X | X | O | O |
| Juvelook / Volume | X | X | O | O |
| Elravie Lituo | X | X | O | X |
| Belotero Revive | O | O | O | O |
| ISANG's Primary Selection | USA | China | Japan | Taiwan |
|---|---|---|---|---|
| Xeomin / Allergan (Toxins) | O | O | O | O |
| Sculptra (PLLA) | O | O | O | O |
Why Regional Availability Differs
While a treatment might be marked with an "X" in your home country, it often reflects bureaucratic timelines rather than medical efficacy. Korea frequently serves as a leading clinical site for these global innovations.
USA: High Standards, Long Timelines
The FDA 510(k) process is thorough and time-consuming. While treatments like Shurink or Rejuran are currently in the trial phase in the US, they have been safely utilized in Korea for years, delivering proven results to millions of patients.
China: Strict New Regulations
With the 2026 NMPA tightening, many energy-based devices are awaiting recertification. ISANG DERMATOLOGY ensures that you can receive these cutting-edge procedures legally and safely while in Korea, before they reach the mainstream market in Mainland China.
Japan & Taiwan: Real-Time Innovation
These regions often mirror Korea’s approval status, making them excellent partners in aesthetic care. However, for specific domestic brands or the latest protocols, Seoul remains the primary destination for the most comprehensive experience.
Experience the Difference in Seoul
Visiting ISANG DERMATOLOGY isn't just about receiving a procedure; it's about gaining early access to the future of skin health. Our consultants are here to help you understand which treatments are best suited for your goals and how to manage your skin journey even after you return home.




Comments
Post a Comment